AnaptysBio, Inc. (ANAB) vs Syndax Pharmaceuticals, Inc. (SNDX)
AnaptysBio, Inc. and Syndax Pharmaceuticals, Inc. are both Biotechnology companies. AnaptysBio, Inc. and Syndax Pharmaceuticals, Inc. are of similar size ($1.6B and $1.6B). Syndax Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 222.3% against 107.7%. AnaptysBio, Inc. has the higher net margin (−11.5% vs −87.6%) and the higher return on invested capital (0.00% vs −247.9%). Across the 18 metrics below, AnaptysBio, Inc. leads on 15 and Syndax Pharmaceuticals, Inc. on 3.
Valuation
Profitability
| Metric | ANAB | SNDX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 95.78% | 65.16% |
| Operating margin | 17.56% | (77.05%) | 0.00% |
| Net margin | (11.53%) | (87.60%) | 0.00% |
| Free cash flow margin | 1.90% | (87.64%) | 0.00% |
| Return on equity | (114.55%) | (255.93%) | (57.72%) |
| Return on assets | (7.13%) | (33.97%) | (49.22%) |
| Return on invested capital | 0.00% | (247.93%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack